Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction 79% responder rate achieved with zero opioid use and quality of life improvement at 7 days post-procedure Company reaches 60% enrollment with 15 patients1 successfully enrolled; No unexpected...

EP Catheter Ablation Market Value to Reach US$ 2.74 billion by the End of 2026: Transparency Market Research Albany – NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Prevalence of cardiovascular conditions such as arrhythmia has fuelled the need for electrophysiology (EP) studies and catheter ablation procedures....